Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 6
1976 4
1977 3
1978 10
1979 11
1980 4
1981 5
1982 11
1983 14
1984 11
1985 11
1986 8
1987 3
1988 6
1989 5
1990 8
1991 2
1992 7
1993 9
1994 8
1995 7
1996 14
1997 20
1998 13
1999 17
2000 33
2001 21
2002 62
2003 33
2004 60
2005 64
2006 72
2007 71
2008 71
2009 64
2010 70
2011 63
2012 78
2013 83
2014 73
2015 61
2016 61
2017 64
2018 61
2019 66
2020 72
2021 73
2022 64
2023 67
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,567 results

Results by year

Filters applied: . Clear all
Page 1
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
de Bartolomeis A, Ciccarelli M, Vellucci L, Fornaro M, Iasevoli F, Barone A. de Bartolomeis A, et al. Expert Opin Pharmacother. 2022 Dec;23(18):2035-2052. doi: 10.1080/14656566.2022.2145884. Epub 2022 Nov 17. Expert Opin Pharmacother. 2022. PMID: 36368055 Review.
EXPERT OPINION: The search for therapy against TRS, beyond clozapine or in addition to clozapine, has emerged over time, capturing mainly three types of strategies: 1. Add-on of a second-generation antipsychotic (i.e. amisulpride); 2. Add-on of a second antipsychotic with …
EXPERT OPINION: The search for therapy against TRS, beyond clozapine or in addition to clozapine, has emerged over time, capturing mainly th …
Amisulpride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2020 Nov 16;77(23):1917-1918. doi: 10.1093/ajhp/zxaa292. Am J Health Syst Pharm. 2020. PMID: 33196816 No abstract available.
Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, Montastruc F. Bordet C, et al. Psychopharmacology (Berl). 2023 Jan;240(1):199-202. doi: 10.1007/s00213-022-06293-4. Epub 2022 Dec 14. Psychopharmacology (Berl). 2023. PMID: 36515735
RATIONALE: While meta-analyses of clinical trials found that lurasidone and partial dopamine agonists (brexpiprazole and aripiprazole) were the antipsychotics less likely to cause QTc prolongation, and sertindole, amisulpride, and ziprasidone were the most frequently assoc …
RATIONALE: While meta-analyses of clinical trials found that lurasidone and partial dopamine agonists (brexpiprazole and aripiprazole) were …
Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.
Long Y, Wu Q, Yang Y, Cai J, Xiao J, Liu Z, Xu Y, Chen Y, Huang M, Zhang R, Xu X, Hu J, Liu Z, Liu F, Zheng Y, Meng H, Wang Z, Tang Y, Song X, Chen Y, Wang X, Liu T, Wu X, Fang M, Wan C, Zhao J, Wu R. Long Y, et al. BMC Med. 2023 Jul 19;21(1):263. doi: 10.1186/s12916-023-02968-7. BMC Med. 2023. PMID: 37468932 Free PMC article. Clinical Trial.

All enrolled participants were assigned to olanzapine, risperidone, amisulpride, or aripiprazole monotherapy for 8 weeks. The positive and negative syndrome scale (PANSS) was evaluated at baseline, week 2, week 4, and week 8. ...RESULTS: At week 2, a reduction of < 5% i

…
All enrolled participants were assigned to olanzapine, risperidone, amisulpride, or aripiprazole monotherapy for 8 weeks. The positiv …
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
Zhu MH, Liu ZJ, Hu QY, Yang JY, Jin Y, Zhu N, Huang Y, Shi DH, Liu MJ, Tan HY, Zhao L, Lv QY, Yi ZH, Wu FC, Li ZZ. Zhu MH, et al. Mil Med Res. 2022 Oct 18;9(1):59. doi: 10.1186/s40779-022-00420-0. Mil Med Res. 2022. PMID: 36253804 Free PMC article. Clinical Trial.
METHODS: A total of 80 patients were recruited and randomly assigned to receive initial clozapine plus amisulpride (amisulpride group) or clozapine plus placebo (placebo group). ...Furthermore, compared with the placebo group, the amisulpride group showed an …
METHODS: A total of 80 patients were recruited and randomly assigned to receive initial clozapine plus amisulpride (amisulpride …
Cannabis and schizophrenia.
McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. McLoughlin BC, et al. Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3. Cochrane Database Syst Rev. 2014. PMID: 25314586 Free PMC article. Review.
Switching to amisulpride.
Peuskens J. Peuskens J. Curr Med Res Opin. 2002;18 Suppl 3:s23-8. doi: 10.1185/030079902125001092. Curr Med Res Opin. 2002. PMID: 12418609 Review.
Cross-tapering old and new treatment is the preferred method for switching and this involves tapering off the previous antipsychotic agent and any adjunctive treatment (sedatives, anticholinergic medication), while gradually titrating the new atypical antipsychotic agent to the e …
Cross-tapering old and new treatment is the preferred method for switching and this involves tapering off the previous antipsychotic agent a …
Focus on amisulpride.
Green B. Green B. Curr Med Res Opin. 2002;18(3):113-7. doi: 10.1185/030079902125000363. Curr Med Res Opin. 2002. PMID: 12094819 Review.
Amisulpride is a second-generation antipsychotic, a substituted benzamide. ...There are interesting studies that point towards amisulpride's antidepressant effect in dysthymia speculative on possible roles in affective psychoses and chronic fatigue syndrome....
Amisulpride is a second-generation antipsychotic, a substituted benzamide. ...There are interesting studies that point towards ami …
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.
Schreyer KF, Leucht S, Heres S, Steimer W. Schreyer KF, et al. Psychopharmacology (Berl). 2023 Apr;240(4):899-908. doi: 10.1007/s00213-023-06331-9. Epub 2023 Feb 9. Psychopharmacology (Berl). 2023. PMID: 36757449 Free PMC article. Clinical Trial.
Up to 252 individuals completed the first 2 weeks (phase I), 212 the entire 8 weeks (hence 'completers'). Patients received either amisulpride or olanzapine or both consecutively. Thirty-seven had their first episode. ...A stepwise multiple linear regression showed a signi …
Up to 252 individuals completed the first 2 weeks (phase I), 212 the entire 8 weeks (hence 'completers'). Patients received either amisul …
[Treatment options for drug-induced sialorrhea: Prescribing guidelines].
Cuvelier E, Gressier B, Fovet T, Simon N, Décaudin B, Amad A. Cuvelier E, et al. Encephale. 2022 Dec;48(6):700-711. doi: 10.1016/j.encep.2022.03.013. Epub 2022 Aug 18. Encephale. 2022. PMID: 35989107 French.
Other agents were described as clinically effective on hypersalivation: dopamine antagonists (9/63) with amisulpride (5/9), alpha-2-adrenergic agonists (5/63) with clonidine (3/5), botulinic toxin (4/63), and terazosine, moclobemide, bupropion and N-acetylcysteine (for eac …
Other agents were described as clinically effective on hypersalivation: dopamine antagonists (9/63) with amisulpride (5/9), alpha-2-a …
1,567 results